Title : PI-3 kinase p110β: a therapeutic target in advanced prostate cancers.

Pub. Date : 2014

PMID : 25374921






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The novel androgen receptor inhibitor Xandi (Enzalutamide) and the new CYP17 inhibitor Zytiga (Abiraterone) prolonged patient survival only a few months in advanced prostate cancers. Abiraterone Acetate cytochrome P450 family 17 subfamily A member 1 Homo sapiens